ROLE OF INTERLEUKIN‐6 IN THE PATHOGENESIS OF MULTIPLE MYELOMA

@article{Gad2000ROLEOI,
  title={ROLE OF INTERLEUKIN‐6 IN THE PATHOGENESIS OF MULTIPLE MYELOMA},
  author={K. Gad{\'o} and G. Domj{\'a}n and H. Hegyesi and A. Falus},
  journal={Cell Biology International},
  year={2000},
  volume={24}
}
  • K. Gadó, G. Domján, +1 author A. Falus
  • Published 2000
  • Biology, Medicine
  • Cell Biology International
  • Multiple myeloma (MM) is a currently incurable disease caused by the proliferation of malignant plasma cells. Although the pathogenesis of the disease still remains unclear, recent research in the biology of MM has produced new insights into the factors that control the growth and survival of myeloma cells. Among the growth factors, interleukin‐6 (IL‐6) has an essential role. Evidence suggests that IL‐6 is not only a growth factor, but also a survival factor in MM, inhibiting apoptosis in… CONTINUE READING
    101 Citations

    Topics from this paper

    Targeting signalling pathways for the treatment of multiple myeloma
    • 31
    The role of IL-29 in immunity and cancer
    • 12
    Activation of sphingosine kinase mediates suppressive effect of interleukin‐6 on human multiple myeloma cell apoptosis
    • 27
    Obesity and Multiple Myeloma
    • 9
    Extracellular S100A9 Protein in Bone Marrow Supports Multiple Myeloma Survival by Stimulating Angiogenesis and Cytokine Secretion
    • 12
    • PDF
    The malignant clone and the bone-marrow environment.
    • 85

    References

    SHOWING 1-10 OF 133 REFERENCES
    Role of cytokines in multiple myeloma.
    • 40
    Interleukin-6 in human multiple myeloma.
    • 558
    • PDF
    Interleukin‐6 in multiple myeloma and related plasma cell dyscrasias
    • 78
    Update of gp130 cytokines in multiple myeloma
    • B. Klein
    • Biology, Medicine
    • Current opinion in hematology
    • 1998
    • 16
    Growth control mechanisms in multiple myeloma.
    • 36
    Cytokine network in human multiple myeloma.
    • 151
    Development of an interleukin (IL) 6 receptor antagonist that inhibits IL-6-dependent growth of human myeloma cells
    • 49
    • PDF
    Growth regulatory pathways in myeloma. Evidence for autocrine oncostatin M expression.
    • 26